J. Fowler
Papers
1
Total Citations
6
H-Index
1
About
J. Fowler is a leading figure in radiation oncology, whose work has fundamentally shaped the clinical application of stereotactic body radiotherapy (SBRT) for lung cancer. His research centers on optimizing dose fractionation to maximize tumor control while minimizing toxicity. In his landmark 2011 feasibility study, Fowler demonstrated that individualized, higher-dose robotic SBRT—delivering 70–75 Gy in five fractions—could improve the therapeutic ratio for peripheral non-small-cell lung cancer (NSCLC) compared to the standard three-fraction regimen. This work challenged conventional dosing limits and opened the door to exploring even higher doses, up to 85 Gy in five fractions, for select patients. With over 6 citations, this paper remains a foundational reference for clinicians seeking to personalize SBRT treatment. Fowler’s contributions have advanced the understanding of radiobiology in hypofractionation, influencing both clinical protocols and future trial design. His rigorous approach to balancing efficacy and safety continues to guide researchers and practitioners striving for better outcomes in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1